Loading…

IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy

Vγ9Vδ2 T lymphocytes are a major human γδ T cell subset that react against a wide array of tumor cells, through recognition of phosphorylated isoprenoid pathway metabolites called phosphoantigens. Immunotherapeutic protocols targeting Vγ9Vδ2 T cells have yielded promising, yet limited, signs of anti...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2009-03, Vol.182 (6), p.3423-3431
Main Authors: Thedrez, Aurélie, Harly, Christelle, Morice, Alexis, Salot, Samuel, Bonneville, Marc, Scotet, Emmanuel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613
cites cdi_FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613
container_end_page 3431
container_issue 6
container_start_page 3423
container_title The Journal of immunology (1950)
container_volume 182
creator Thedrez, Aurélie
Harly, Christelle
Morice, Alexis
Salot, Samuel
Bonneville, Marc
Scotet, Emmanuel
description Vγ9Vδ2 T lymphocytes are a major human γδ T cell subset that react against a wide array of tumor cells, through recognition of phosphorylated isoprenoid pathway metabolites called phosphoantigens. Immunotherapeutic protocols targeting Vγ9Vδ2 T cells have yielded promising, yet limited, signs of antitumor efficacy. To improve these approaches, we analyzed the effects on γδ T cells of IL-21, a cytokine known to enhance proliferation and effector functions of CD8+ T cells and NK cells. IL-21 induced limited division of phosphoantigen-stimulated Vγ9Vδ2 T cells, but did not modulate their sustained expansion induced by exogenous IL-2. Vγ9Vδ2 T cells expanded in the presence of IL-21 and IL-2 showed enhanced antitumor cytolytic responses, associated with increased expression of CD56 and several lytic molecules, and increased tumor-induced degranulation capacity. IL-21 plus IL-2-expanded Vγ9Vδ2 T cells expressed higher levels of inhibitory receptors (e.g., ILT2 and NKG2A) and lower levels of the costimulatory molecule NKG2D. Importantly, these changes were rapidly and reversibly induced after short-term culture with IL-21. Finally, IL-21 irreversibly enhanced the proinflammatory Th1 polarization of expanded Vγ9Vδ2 T cells when added at the beginning of the culture. These data suggest a new role played by IL-21 in the cytotoxic and Th1 programming of precommitted Ag-stimulated γδ T cells. On a more applied standpoint, IL-21 could be combined to IL-2 to enhance γδ T cell-mediated antitumor responses, and thus represents a promising way to optimize immunotherapies targeting this cell subset.
doi_str_mv 10.4049/jimmunol.0803068
format article
fullrecord <record><control><sourceid>hal_cross</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_inserm_03537940v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_inserm_03537940v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613</originalsourceid><addsrcrecordid>eNo9kU1OwzAUhC0EglLYs_QBSHn-d5ZVBbRSEQhBt5GbOMIoiSvbRcoBOBGco2ci5W_15knfjEYahC4ITDjw_OrVte22880ENDCQ-gCNiBCQSQnyEI0AKM2IkuoEncb4CgASKD9GJySnUhAKI_S-WGaUZHe2cibZCj_4ZLs0aOc77Gs8HZ60bX3Asz75pk-uxKYbuOBdVzembU3yocePNm58F23cm-bb1nR4tfvIV7tPip_wzDZNxPWQMq38Jrk3ixffzdOLDWbTn6Gj2jTRnv_eMXq-uX6azbPl_e1iNl1mJclFymqmhCGKSyZLYmsuQZVrCtqIai1yoRSxTAuujQSmKy2ornIlqeZKSU4lYWN0-ZP7YppiE1xrQl9444r5dFm4oX5oC2CCqZzD2x6HH7wMPsZg638PgWI_QPE3QPE7APsCJb96iA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy</title><source>EZB Electronic Journals Library</source><creator>Thedrez, Aurélie ; Harly, Christelle ; Morice, Alexis ; Salot, Samuel ; Bonneville, Marc ; Scotet, Emmanuel</creator><creatorcontrib>Thedrez, Aurélie ; Harly, Christelle ; Morice, Alexis ; Salot, Samuel ; Bonneville, Marc ; Scotet, Emmanuel</creatorcontrib><description>Vγ9Vδ2 T lymphocytes are a major human γδ T cell subset that react against a wide array of tumor cells, through recognition of phosphorylated isoprenoid pathway metabolites called phosphoantigens. Immunotherapeutic protocols targeting Vγ9Vδ2 T cells have yielded promising, yet limited, signs of antitumor efficacy. To improve these approaches, we analyzed the effects on γδ T cells of IL-21, a cytokine known to enhance proliferation and effector functions of CD8+ T cells and NK cells. IL-21 induced limited division of phosphoantigen-stimulated Vγ9Vδ2 T cells, but did not modulate their sustained expansion induced by exogenous IL-2. Vγ9Vδ2 T cells expanded in the presence of IL-21 and IL-2 showed enhanced antitumor cytolytic responses, associated with increased expression of CD56 and several lytic molecules, and increased tumor-induced degranulation capacity. IL-21 plus IL-2-expanded Vγ9Vδ2 T cells expressed higher levels of inhibitory receptors (e.g., ILT2 and NKG2A) and lower levels of the costimulatory molecule NKG2D. Importantly, these changes were rapidly and reversibly induced after short-term culture with IL-21. Finally, IL-21 irreversibly enhanced the proinflammatory Th1 polarization of expanded Vγ9Vδ2 T cells when added at the beginning of the culture. These data suggest a new role played by IL-21 in the cytotoxic and Th1 programming of precommitted Ag-stimulated γδ T cells. On a more applied standpoint, IL-21 could be combined to IL-2 to enhance γδ T cell-mediated antitumor responses, and thus represents a promising way to optimize immunotherapies targeting this cell subset.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.0803068</identifier><identifier>PMID: 19265120</identifier><language>eng</language><publisher>Publisher : Baltimore : Williams &amp; Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists</publisher><subject>Life Sciences</subject><ispartof>The Journal of immunology (1950), 2009-03, Vol.182 (6), p.3423-3431</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613</citedby><cites>FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613</cites><orcidid>0000-0002-8045-9166</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://inserm.hal.science/inserm-03537940$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Thedrez, Aurélie</creatorcontrib><creatorcontrib>Harly, Christelle</creatorcontrib><creatorcontrib>Morice, Alexis</creatorcontrib><creatorcontrib>Salot, Samuel</creatorcontrib><creatorcontrib>Bonneville, Marc</creatorcontrib><creatorcontrib>Scotet, Emmanuel</creatorcontrib><title>IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy</title><title>The Journal of immunology (1950)</title><description>Vγ9Vδ2 T lymphocytes are a major human γδ T cell subset that react against a wide array of tumor cells, through recognition of phosphorylated isoprenoid pathway metabolites called phosphoantigens. Immunotherapeutic protocols targeting Vγ9Vδ2 T cells have yielded promising, yet limited, signs of antitumor efficacy. To improve these approaches, we analyzed the effects on γδ T cells of IL-21, a cytokine known to enhance proliferation and effector functions of CD8+ T cells and NK cells. IL-21 induced limited division of phosphoantigen-stimulated Vγ9Vδ2 T cells, but did not modulate their sustained expansion induced by exogenous IL-2. Vγ9Vδ2 T cells expanded in the presence of IL-21 and IL-2 showed enhanced antitumor cytolytic responses, associated with increased expression of CD56 and several lytic molecules, and increased tumor-induced degranulation capacity. IL-21 plus IL-2-expanded Vγ9Vδ2 T cells expressed higher levels of inhibitory receptors (e.g., ILT2 and NKG2A) and lower levels of the costimulatory molecule NKG2D. Importantly, these changes were rapidly and reversibly induced after short-term culture with IL-21. Finally, IL-21 irreversibly enhanced the proinflammatory Th1 polarization of expanded Vγ9Vδ2 T cells when added at the beginning of the culture. These data suggest a new role played by IL-21 in the cytotoxic and Th1 programming of precommitted Ag-stimulated γδ T cells. On a more applied standpoint, IL-21 could be combined to IL-2 to enhance γδ T cell-mediated antitumor responses, and thus represents a promising way to optimize immunotherapies targeting this cell subset.</description><subject>Life Sciences</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNo9kU1OwzAUhC0EglLYs_QBSHn-d5ZVBbRSEQhBt5GbOMIoiSvbRcoBOBGco2ci5W_15knfjEYahC4ITDjw_OrVte22880ENDCQ-gCNiBCQSQnyEI0AKM2IkuoEncb4CgASKD9GJySnUhAKI_S-WGaUZHe2cibZCj_4ZLs0aOc77Gs8HZ60bX3Asz75pk-uxKYbuOBdVzembU3yocePNm58F23cm-bb1nR4tfvIV7tPip_wzDZNxPWQMq38Jrk3ixffzdOLDWbTn6Gj2jTRnv_eMXq-uX6azbPl_e1iNl1mJclFymqmhCGKSyZLYmsuQZVrCtqIai1yoRSxTAuujQSmKy2ornIlqeZKSU4lYWN0-ZP7YppiE1xrQl9444r5dFm4oX5oC2CCqZzD2x6HH7wMPsZg638PgWI_QPE3QPE7APsCJb96iA</recordid><startdate>20090315</startdate><enddate>20090315</enddate><creator>Thedrez, Aurélie</creator><creator>Harly, Christelle</creator><creator>Morice, Alexis</creator><creator>Salot, Samuel</creator><creator>Bonneville, Marc</creator><creator>Scotet, Emmanuel</creator><general>Publisher : Baltimore : Williams &amp; Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists</general><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-8045-9166</orcidid></search><sort><creationdate>20090315</creationdate><title>IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy</title><author>Thedrez, Aurélie ; Harly, Christelle ; Morice, Alexis ; Salot, Samuel ; Bonneville, Marc ; Scotet, Emmanuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thedrez, Aurélie</creatorcontrib><creatorcontrib>Harly, Christelle</creatorcontrib><creatorcontrib>Morice, Alexis</creatorcontrib><creatorcontrib>Salot, Samuel</creatorcontrib><creatorcontrib>Bonneville, Marc</creatorcontrib><creatorcontrib>Scotet, Emmanuel</creatorcontrib><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thedrez, Aurélie</au><au>Harly, Christelle</au><au>Morice, Alexis</au><au>Salot, Samuel</au><au>Bonneville, Marc</au><au>Scotet, Emmanuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy</atitle><jtitle>The Journal of immunology (1950)</jtitle><date>2009-03-15</date><risdate>2009</risdate><volume>182</volume><issue>6</issue><spage>3423</spage><epage>3431</epage><pages>3423-3431</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Vγ9Vδ2 T lymphocytes are a major human γδ T cell subset that react against a wide array of tumor cells, through recognition of phosphorylated isoprenoid pathway metabolites called phosphoantigens. Immunotherapeutic protocols targeting Vγ9Vδ2 T cells have yielded promising, yet limited, signs of antitumor efficacy. To improve these approaches, we analyzed the effects on γδ T cells of IL-21, a cytokine known to enhance proliferation and effector functions of CD8+ T cells and NK cells. IL-21 induced limited division of phosphoantigen-stimulated Vγ9Vδ2 T cells, but did not modulate their sustained expansion induced by exogenous IL-2. Vγ9Vδ2 T cells expanded in the presence of IL-21 and IL-2 showed enhanced antitumor cytolytic responses, associated with increased expression of CD56 and several lytic molecules, and increased tumor-induced degranulation capacity. IL-21 plus IL-2-expanded Vγ9Vδ2 T cells expressed higher levels of inhibitory receptors (e.g., ILT2 and NKG2A) and lower levels of the costimulatory molecule NKG2D. Importantly, these changes were rapidly and reversibly induced after short-term culture with IL-21. Finally, IL-21 irreversibly enhanced the proinflammatory Th1 polarization of expanded Vγ9Vδ2 T cells when added at the beginning of the culture. These data suggest a new role played by IL-21 in the cytotoxic and Th1 programming of precommitted Ag-stimulated γδ T cells. On a more applied standpoint, IL-21 could be combined to IL-2 to enhance γδ T cell-mediated antitumor responses, and thus represents a promising way to optimize immunotherapies targeting this cell subset.</abstract><pub>Publisher : Baltimore : Williams &amp; Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists</pub><pmid>19265120</pmid><doi>10.4049/jimmunol.0803068</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8045-9166</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2009-03, Vol.182 (6), p.3423-3431
issn 0022-1767
1550-6606
language eng
recordid cdi_hal_primary_oai_HAL_inserm_03537940v1
source EZB Electronic Journals Library
subjects Life Sciences
title IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL-21-Mediated%20Potentiation%20of%20Antitumor%20Cytolytic%20and%20Proinflammatory%20Responses%20of%20Human%20V%CE%B39V%CE%B42%20T%20Cells%20for%20Adoptive%20Immunotherapy&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Thedrez,%20Aure%CC%81lie&rft.date=2009-03-15&rft.volume=182&rft.issue=6&rft.spage=3423&rft.epage=3431&rft.pages=3423-3431&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.0803068&rft_dat=%3Chal_cross%3Eoai_HAL_inserm_03537940v1%3C/hal_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c195t-f375a174636c1ef4607cb208a5db595771e38548a6038d8528d97628477642613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19265120&rfr_iscdi=true